Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
02/26/2004 | US20040038891 Contacting the tissue or organ with an effective amount of an apolipoprotein to treat, prevent or reduce ischemic reperfusion injury |
02/26/2004 | US20040038885 Carriers for administration of active principles such as drugs or nutriments, cosmetic products or plant health products such as herbicides, pesticides, insecticides, fungicides, etc. |
02/26/2004 | US20040038878 Injectable protein formulations |
02/26/2004 | US20040038865 Contacting a proximal face of the membrane or bilayer with a complex comprising the compound and diketopiperazine (DKP), wherein transport of compound from proximal face of the lipid bilayer to a distal face of lipid bilayer is increased |
02/26/2004 | US20040038864 Use of dimethyl sulfone as isotonicity agent |
02/26/2004 | US20040038406 Nanoparticle delivery systems and methods of use thereof |
02/26/2004 | US20040038303 Comprises use of small particle with appropriate hydrophilic-lipophilic-balance value to deliver anticarcinogenic agents to cells and/or tissues; drug screening |
02/26/2004 | US20040037911 Genital lubricating compositions and uses thereof |
02/26/2004 | US20040037907 Parenteral pimaricin as treatment of systemic infections |
02/26/2004 | US20040037897 Treatment of drug resistant organisms |
02/26/2004 | US20040037893 Aqueous composition also including a buffer to keep the pH in the range of 4.0-8.0, a salt of calcium and/or magnesium in a concentration of >15 mM; stabilised against chemical and/ or physical degradation during storage or transportation |
02/26/2004 | US20040037890 Moisture and oxygen stable composition and a process for obtaining said composition |
02/26/2004 | US20040037889 Stabilized, dry pharmaceutical compositions for drug delivery and methods of preparing same |
02/26/2004 | US20040037888 Administering intrarectally or to anorectal region aqueous gel composition containing drug effective in such treatment and carrier comprising water soluble cellulose derivative gelling agent, propylene glycol, water |
02/26/2004 | US20040037885 Amphiphilic diblock copolymer, poorly water-soluble drug, biodegradable polymer, liquid poly(ethylene glycol); composition forms implant containing drug and drug containing polymeric micelles, which are slowly released |
02/26/2004 | US20040037884 Novel dosage forms of risedronate |
02/26/2004 | US20040037883 Controlled release dosage forms |
02/26/2004 | US20040037882 Opioid agonist in a fast dispersing dosage form |
02/26/2004 | US20040037881 Administering composition and dosage form comprising oxybutynin alone/or accompanied by another drug indicated for therapy |
02/26/2004 | US20040037880 Extended release formulation of divalproex sodium |
02/26/2004 | US20040037879 Oral controlled release forms useful for reducing or preventing nicotine cravings |
02/26/2004 | US20040037878 Fast dissolving tablet |
02/26/2004 | US20040037877 Flavored gelatin capsule and method of manufacture |
02/26/2004 | US20040037875 Composition for treatment of inflammatory disorders |
02/26/2004 | US20040037874 Delivery of nucleic acid-like compounds |
02/26/2004 | US20040037873 Norethindrone sustained release formulations and methods associated therewith |
02/26/2004 | US20040037872 Active substance-containing adhesive patch comprising diclofenac or a topically acceptable salt thereof; patch composed of outer impermeable backing layer, matrix layer comprising active substance, removable protective layer |
02/26/2004 | US20040037870 Patch provides volatile substance within solid layer positioned between breathable layer and barrier layer; release liner is removably adhered to barrier layer |
02/26/2004 | US20040037869 Comprises pharmaceutical agent, binder, disintegrant, non-animal product containing flavor or flavor derived from a non-animal source, humectant, granulating solvent, optionally, antioxidants, buffers, preservatives |
02/26/2004 | US20040037819 Non-polymeric hematopoeitic cell clots for delivery of active agents |
02/26/2004 | US20040037809 Intranasal delivery of interferon- beta yielding improved pharmacokinetic and pharmacodynamic results. In certain aspects of the invention, the interferon- beta is delivered to the intranasal mucosa along with one or more intranasal |
02/26/2004 | US20040037797 Water-in-oil emulsions containing one or more ammonium acryloylodimethyltaurate/vinylpyrrolidone copolymers |
02/26/2004 | US20040037788 A gum, lollipop and lozenge having at least two separate components, with at least one of such components containing amounts of herbal, medicinal and/or mineral elements or combinations thereof to enhance metabolism |
02/26/2004 | US20040037785 Method of making particles for use in a pharmaceutical composition |
02/26/2004 | US20040037784 Particulate (2S)-3-(4-(((4-(aminocarbonyl)-1-piperidinyl) carbonyl)oxy)phenyl)-2-(((2S)-4-methyl-2-((2-(2-methylphenoxy) acetyl)amino)pentanoyl)amino) propanoic acid or a salt or solvate thereof and one or more suitable excipients for |
02/26/2004 | US20040037783 Pharmaceutical formulation of fluticasone propionate |
02/26/2004 | US20040037778 Iodinated and/or brominated derivatives of aromatic dihydroxy monomers are prepared and polymerized to form radio-opaque polymers. The monomers may also be copolymerized with other dihydroxy monomers. The iodinated and brominated aromatic |
02/26/2004 | US20040037766 A skin treatment composition containing ionic calcium and a dermatologically acceptable water-soluble, water-miscible or water-based carrier is provided for treating a skin condition in a mammal, such as dry skin, dry scalp, a burn, sunburn, |
02/26/2004 | DE20318634U1 Topical compositions for preventing or treating rhinitis, comprising sympathomimetic agent with vasoconstrictive and/or mucosal swelling reducing action and glycosaminoglycan to reduce side-effects |
02/26/2004 | DE20220604U1 Zusammensetzung, enthaltend feine Partikel zur Langzeitfreisetzung für schnell in der Mundhöhle zerfallende Tabletten Composition containing fine particles for sustained release of rapidly disintegrating in the oral cavity tablets |
02/26/2004 | DE19834496B4 Verbesserte Freisetzung von Ibuprofen aus Heißschmelzklebemassen in wirkstoffhaltigen Pflastern durch Zusatz von pharmazeutischen Hilfsstoffen und Verwendung von Hilfsstoffen zur Verbesserung der Freisetzung von Ibuprofen Enhanced release of ibuprofen from hot melt adhesives in active substance patches by the addition of pharmaceutical excipients and use of adjuvants to enhance the release of ibuprofen |
02/26/2004 | DE10238162A1 Carrier solution for foods, essential ingredients or dietetically- or pharmacologically-active materials contains a thickener |
02/26/2004 | DE10238161A1 Mucosal or topical administration of minerals, e.g. for treating muscle spasms, psoriasis or osteoporosis or promoting wound healing, comprises direct application of mineral solution from ampoule |
02/26/2004 | DE10237232A1 Aqueous solution for inhalation, useful for treating respiratory disease, contains anticholinergic tricyclo-oxa-aza-nonane derivative and requires no propellant |
02/26/2004 | CA2854798A1 Anti-tnf-alpha antibodies in solution and uses thereof |
02/26/2004 | CA2496044A1 A process for manufacture of stable oral multiple units pharamceutical composition containing benzimidazoles |
02/26/2004 | CA2495956A1 Sulfonamides as potassium channel blockers |
02/26/2004 | CA2495401A1 Optimal volume of intra-vaginal semisolid dosage forms for treating vaginal infections |
02/26/2004 | CA2495345A1 Topical anhydrous and ethanol-free ascomycin compositions |
02/26/2004 | CA2495291A1 Galenic formulation for colon targeted delivery of active principles |
02/26/2004 | CA2494756A1 Anti-tnf-alpha antibodies in solution and uses thereof |
02/26/2004 | CA2494580A1 Threaded syringe with quick stop |
02/26/2004 | CA2494147A1 Pharmaceutical compositions for buccal delivery of pain relief medications |
02/26/2004 | CA2494132A1 Pharmaceutical composition, metered dose dispenser containing same, and use of pharmaceutical composition and metered dose dispenser in administering pharmaceutical agent to oral membranes |
02/26/2004 | CA2494002A1 Antigenic compositions |
02/25/2004 | EP1391513A1 IL-7 drug substance, IL-7 comprising composition, preparation and uses thereof |
02/25/2004 | EP1391458A2 Novel method for producing 5-aryloxymethyl-2-oxazolidinones |
02/25/2004 | EP1391426A1 Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
02/25/2004 | EP1391214A1 Gene transfer of angiogenic factor for skin disease |
02/25/2004 | EP1391212A1 Oral preparations and supports for oral preparations |
02/25/2004 | EP1391206A1 Pharmaceutical compositions comprising arsenic for the treatment of lymphoma |
02/25/2004 | EP1391202A1 Liquid drug preparations |
02/25/2004 | EP1391201A1 Medicinal compositions |
02/25/2004 | EP1391200A1 Drug preparations |
02/25/2004 | EP1390866A2 Container and method for dispensing transdermal dosage forms |
02/25/2004 | EP1390740A1 Methods and formulations for increasing the affinity of a 1? adenosine receptor ligands for the a 1? adenosine receptor |
02/25/2004 | EP1390699A1 Metering method for particulate material |
02/25/2004 | EP1390569A2 Method for manufacture of fine particles |
02/25/2004 | EP1390495A2 Immunostimulatory oligodeoxynucleic molecules |
02/25/2004 | EP1390494A2 Method for stabilising of nucleic acids |
02/25/2004 | EP1390385A2 Nucleic acid based modulation of female reproductive diseases and conditions |
02/25/2004 | EP1390383A1 Antisense permeation enhancers |
02/25/2004 | EP1390377A1 Crystal forms of azithromycin |
02/25/2004 | EP1390138A1 Vegetable protein-based microcapsules |
02/25/2004 | EP1390085A1 Hydrogel compositions |
02/25/2004 | EP1390084A2 Two-phase, water-absorbent bioadhesive composition |
02/25/2004 | EP1390077A2 Treatment and diagnosis of macrophage mediated disease |
02/25/2004 | EP1390063A2 Pharmaceutical dosage form of amorphous nelfinavir mesylate |
02/25/2004 | EP1390053A2 Hcg formulation |
02/25/2004 | EP1390048A2 Oral formulations containing mucopolysaccharide for small intestine delivery and their use in the treatment circulatory disorders |
02/25/2004 | EP1390047A1 Taste masking pharmaceutical composition |
02/25/2004 | EP1390044A1 Injectable pamidronate disodium |
02/25/2004 | EP1390041A1 Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception |
02/25/2004 | EP1390040A1 Pharmaceutical composition for use in hormone replacement therapy |
02/25/2004 | EP1390039A1 Use of estrogen compounds to increase libido in women |
02/25/2004 | EP1390037A1 Methods for treating delirium using glucocorticoid receptor-specific antagonists |
02/25/2004 | EP1390036A1 Prostanoic acid derivatives as agents for lowering intraocular pressure |
02/25/2004 | EP1390035A1 Method for treating ocular hypertension and glaucoma |
02/25/2004 | EP1390031A2 Topical composition containing a fungicide |
02/25/2004 | EP1390023A2 Pharmaceutical salts |
02/25/2004 | EP1390021A1 Delivery of compounds for the treatment of migraine through an inhalation route |
02/25/2004 | EP1390019A1 Controlled release drug delivery device |
02/25/2004 | EP1390018A1 A pharmaceutical tablet having a high api content |
02/25/2004 | EP1390016A2 Echogenic polymer microcapsules and nanocapsules and methods for production and use thereof |
02/25/2004 | EP1390015A1 Taste-masking of highly water-soluble drugs |
02/25/2004 | EP1390014A1 Composition and methods for treatment of hyperplasia |
02/25/2004 | EP1390013A2 Therapeutic treatments using the direct application of antimicrobial metal compositions |
02/25/2004 | EP1390012A1 Novel methods and compositions for delivering macromolecules to or via the respiratory tract |
02/25/2004 | EP1390011A2 Control of compactability through crystallization |
02/25/2004 | EP1390007A1 Cosmetic composition based on zinc and copper sulphates and sucralphate |